Shingrix

Product

GSK's recombinant shingles vaccine approved by the FDA in 2017

2 stories

FDA Withdraws Publication of COVID and Shingles Vaccine Research Findings

Study Finds Vaccine Reduces Alzheimer's Disease Risk by 55 Percent